{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:52Z","timestamp":1786982752738,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010377","name":"National Institute for Health and Care Excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s40258-018-0389-3","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T04:50:36Z","timestamp":1522731036000},"page":"445-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Memokath-051 Stent for the Treatment of Ureteric Obstruction: A NICE Medical Technology Guidance"],"prefix":"10.1007","volume":"16","author":[{"given":"Emily","family":"Eaton Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Jenks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"McCool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Peel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"issue":"5","key":"389_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF03261863","volume":"10","author":"B Campbell","year":"2012","unstructured":"Campbell B, Campbell M. NICE medical technologies guidance: a novel and rigorous methodology to address a new health technology assessment challenge. Appl Health Econ Health Policy. 2012;10(5):295\u20137.","journal-title":"Appl Health Econ Health Policy."},{"issue":"7","key":"389_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1046\/j.1464-410x.1999.00054.x","volume":"83","author":"RP Kulkarni","year":"1999","unstructured":"Kulkarni RP, Bellamy EA. A new thermo-expandable shape-memory nickel-titanium alloy stent for the management of ureteric strictures. BJU Int. 1999;83(7):755\u20139.","journal-title":"BJU Int."},{"key":"389_CR3","volume-title":"Medical technologies evaluation programme process guide","author":"National Institute for Health and Care Excellence (NICE)","year":"2017","unstructured":"National Institute for Health and Care Excellence (NICE). Medical technologies evaluation programme process guide. London: NICE; 2017."},{"key":"389_CR4","doi-asserted-by":"crossref","unstructured":"Eaton Turner E, Jenks M, Marshall C, McCool R, Wood H, Peel A et al. The Memokath-051 stent for the treatment of ureteric obstruction (assessment report). 2017.","DOI":"10.1007\/s40258-018-0389-3"},{"key":"389_CR5","unstructured":"National Institute for Health and Care Excellence. Memokath-051 stent for ureteral obstruction. 2017. https:\/\/www.nice.org.uk\/guidance\/indevelopment\/gid-mt512 ."},{"key":"389_CR6","unstructured":"NHS North Bristol Trust. Having a ureteric stent: what to expect and how to manage. 2014. https:\/\/www.nbt.nhs.uk\/sites\/default\/files\/attachments\/Having%20a%20Ureteric%20Stent_NBT002639.pdf . Accessed 10th May 2017."},{"issue":"4","key":"389_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/end.2009.0318","volume":"24","author":"Z Maan","year":"2010","unstructured":"Maan Z, Patel D, Moraitis K, El-Husseiny T, Papatsoris AG, Buchholz N-P, et al. Comparison of stent-related symptoms between conventional double-J stents and a new-generation thermoexpandable segmental metallic stent: a validated-questionnaire-based study. J Endourol. 2010;24(4):589\u201393. https:\/\/doi.org\/10.1089\/end.2009.0318 .","journal-title":"J Endourol"},{"issue":"1","key":"389_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.aju.2012.12.005","volume":"11","author":"MM Abdallah","year":"2013","unstructured":"Abdallah MM, Selim M, Abdelbakey T. Thermo-expandable metallic urethral stents for managing recurrent bulbar urethral strictures: to use or not? Arab J Urol. 2013;11(1):85\u201390. https:\/\/doi.org\/10.1016\/j.aju.2012.12.005 .","journal-title":"Arab J Urol"},{"key":"389_CR9","unstructured":"National Institute for Health and Care Excellence. Memokath-051 stent for ureteral obstruction: final scope. 2017. https:\/\/www.nice.org.uk\/guidance\/indevelopment\/gid-mt512\/documents ."},{"issue":"8","key":"389_CR10","doi-asserted-by":"publisher","first-page":"e0135566","DOI":"10.1371\/journal.pone.0135566","volume":"10","author":"P-M Chow","year":"2015","unstructured":"Chow P-M, Chiang IN, Chen C-Y, Huang K-H, Hsu J-S, Wang S-M, et al. Malignant ureteral obstruction: functional duration of metallic versus polymeric ureteral stents. PLoS One. 2015;10(8):e0135566. https:\/\/doi.org\/10.1371\/journal.pone.0135566 .","journal-title":"PLoS One"},{"issue":"3","key":"389_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ajur.2016.04.002","volume":"3","author":"K Pavlovic","year":"2016","unstructured":"Pavlovic K, Lange D, Chew B. Stents for malignant ureteral obstruction. Asian Journal of Urology. 2016;3(3):142\u20139.","journal-title":"Asian Journal of Urology."},{"key":"389_CR12","unstructured":"Health and Social Care Information Centre. Hospital Episode Statistics, Admitted Patient Care - England, 2014-15: Procedures and interventions: 4 character. 2015. http:\/\/content.digital.nhs.uk\/catalogue\/PUB19124 . Accessed 11 May 2017."},{"key":"389_CR13","unstructured":"Cook Medical. Resonance metallic ureteral stent set: instructions for use. United States: Cook Medical. 2012. https:\/\/www.cookmedical.com\/data\/IFU_PDF\/IFU0020-14.PDF . Accessed 11 May 2017."},{"key":"389_CR14","unstructured":"National Institute for Health and Care Excellence. Briefing note for the selection and routing of: the Memokath-051 stent for ureteral obstruction; 2017 (unpublished)."},{"key":"389_CR15","unstructured":"Allium Medical. Allium ureteral stent (URS): instructions for use. Kingdom: Allium. 2016. http:\/\/www.alliummedical.com\/uploads\/images\/IFU%20for%20URS-243-0217-Brochure.pdf . Accessed 11 May 2017."},{"issue":"12","key":"389_CR16","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1089\/end.2013.0180","volume":"27","author":"C Bach","year":"2013","unstructured":"Bach C, Kabir MN, Goyal A, Malliwal R, Kachrilas S, El Howairis ME, et al. A self-expanding thermolabile nitinol stent as a minimally invasive treatment alternative for ureteral strictures in renal transplant patients. J Endourol. 2013;27(12):1543\u20135. https:\/\/doi.org\/10.1089\/end.2013.0180 .","journal-title":"J Endourol"},{"key":"389_CR17","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/j.juro.2010.02.850","volume":"1","author":"C Granberg","year":"2010","unstructured":"Granberg C, Russell S, Siddiqui S, Nehra A, Frie K, Leroy A, et al. Long term drainage of malignant extrinsic ureteral obstruction secondary to inoperable pelvic or abdominal malignancies using the Memokath 051 ureteral stent. J Urol. 2010;1:e495. https:\/\/doi.org\/10.1016\/j.juro.2010.02.850 .","journal-title":"J Urol."},{"key":"389_CR18","unstructured":"NHS Supply Chain. 2017. https:\/\/my.supplychain.nhs.uk\/catalogue\/search?query=double-J%20stent . Accessed 11 May 2017."},{"key":"389_CR19","unstructured":"Mayo Clinic. Drainage of malignant extrinsic ureteral obstruction using the Memokath ureteral stent. Identifier: NCT00166361. In: ClinicalTrials.gov. Bethesda. US National Library of Medicine. 2014. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00166361 ."},{"issue":"3","key":"389_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1464-410X.2008.08018.x","volume":"103","author":"S Agrawal","year":"2009","unstructured":"Agrawal S, Brown CT, Bellamy EA, Kulkarni R. The thermo-expandable metallic ureteric stent: an 11-year follow-up. BJU Int. 2009;103(3):372\u20136. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08018.x .","journal-title":"BJU Int."},{"issue":"5","key":"389_CR21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0022-5347(05)65667-4","volume":"166","author":"R Kulkarni","year":"2001","unstructured":"Kulkarni R, Bellamy E. Nickel-titanium shape memory alloy Memokath 051 ureteral stent for managing long-term ureteral obstruction: 4-year experience. J Urol. 2001;166(5):1750\u20134.","journal-title":"J Urol"},{"key":"389_CR22","first-page":"1","volume":"21","author":"A Papatsoris","year":"2007","unstructured":"Papatsoris A, Masood J, El-Husseiny T, Ndirika S, Buchholz N. A novel long-term thermo-expandable ureteric metal stent: Memokath 051. BJU Int. 2007;21:1\u201310.","journal-title":"BJU Int"},{"issue":"2","key":"389_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000327454","volume":"5","author":"D Patel","year":"2011","unstructured":"Patel D, Maan Z, El-Husseiny T, Moraitis K, Junaid I, Buchholz N, et al. Characterising stent symptoms associated with a segmental thermo-expandable metallic stent using a validated stent symptoms questionnaire. Curr Urol. 2011;5(2):72\u20138. https:\/\/doi.org\/10.1159\/000327454 .","journal-title":"Curr Urol"},{"issue":"3","key":"389_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/end.2009.0138","volume":"24","author":"AG Papatsoris","year":"2010","unstructured":"Papatsoris AG, Buchholz N. A novel thermo-expandable ureteral metal stent for the minimally invasive management of ureteral strictures. J Endourol. 2010;24(3):487\u201391. https:\/\/doi.org\/10.1089\/end.2009.0138 .","journal-title":"J Endourol"},{"issue":"8","key":"389_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/lap.2014.0056","volume":"24","author":"KS Kim","year":"2014","unstructured":"Kim KS, Choi S, Choi YS, Bae WJ, Hong S-H, Lee JY, et al. Comparison of efficacy and safety between a segmental thermo-expandable metal alloy spiral stent (Memokath 051) and a self-expandable covered metallic stent (UVENTA) in the management of ureteral obstructions. J Laparoendosc Adv Surg Tech A. 2014;24(8):550\u20135. https:\/\/doi.org\/10.1089\/lap.2014.0056 .","journal-title":"J Laparoendosc Adv Surg Tech A."},{"issue":"4","key":"389_CR26","doi-asserted-by":"publisher","first-page":"E303","DOI":"10.1016\/j.juro.2017.02.3299","volume":"197","author":"I Akbarov","year":"2017","unstructured":"Akbarov I, Al-Mahmid M, Pfister D, Heidenreich A. Upper urinary tract decompression using ileal ureter replacement in comparison to endoureteral thermoexpandable stent [Memokath 051]. J Urol. 2017;197(4):E303\u20134.","journal-title":"J Urol"},{"key":"389_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bju.13221","volume":"116","author":"EM Bolton","year":"2015","unstructured":"Bolton EM, Considine S, Moran D, Siddiqui R, Cham A, Nusrat N, et al. Tailored length permanent stents for the treatment of ureteric obstruction. BJU Int. 2015;116:25. https:\/\/doi.org\/10.1111\/bju.13221 .","journal-title":"BJU Int"},{"key":"389_CR28","unstructured":"Nam J, Han J, Lee D, Park S, Chung M. Comparison of initial experiences between full-length metallic stent and segmental metallic stent in malignant ureteral obstruction. In: World Congress of Endourology and SWL Annual Meeting 2015. pp P1-A457."},{"issue":"4","key":"389_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1464-410X.2001.02322.x","volume":"88","author":"M Arya","year":"2001","unstructured":"Arya M, Mostafid H, Patel HR, Kellett MJ, Philp T. The self-expanding metallic ureteric stent in the long-term management of benign ureteric strictures. BJU Int. 2001;88(4):339\u201342.","journal-title":"BJU Int"},{"issue":"1","key":"389_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/end.2013.0332","volume":"28","author":"A Bourdoumis","year":"2014","unstructured":"Bourdoumis A, Kachrilas S, Kapoor S, Zaman F, Papadopoulos G, Buchholz N, et al. The use of a thermoexpandable metal alloy stent in the minimally invasive management of retroperitoneal fibrosis: a single center experience from the United kingdom. J Endourol. 2014;28(1):96\u20139. https:\/\/doi.org\/10.1089\/end.2013.0332 .","journal-title":"J Endourol"},{"issue":"3","key":"389_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00270-004-0028-2","volume":"28","author":"F Boyvat","year":"2005","unstructured":"Boyvat F, Aytekin C, Colak T, Firat A, Karakayali H, Haberal M. Memokath metallic stent in the treatment of transplant kidney ureter stenosis or occlusion. Cardiovasc Interv Radiol. 2005;28(3):326\u201330. https:\/\/doi.org\/10.1007\/s00270-004-0028-2 .","journal-title":"Cardiovasc Interv Radiol"},{"issue":"2","key":"389_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/00365590510007720","volume":"39","author":"P Klarskov","year":"2005","unstructured":"Klarskov P, Nordling J, Nielsen JB. Experience with Memokath 051 ureteral stent. Scand J Urol Nephrol. 2005;39(2):169\u201372. https:\/\/doi.org\/10.1080\/00365590510007720 .","journal-title":"Scand J Urol Nephrol"},{"issue":"3","key":"389_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000288230","volume":"84","author":"GI Papadopoulos","year":"2010","unstructured":"Papadopoulos GI, Middela S, Srirangam SJ, Szczesniak CA, Rao PN. Use of Memokath 051 metallic stent in the management of ureteral strictures: a single-center experience. Urol Int. 2010;84(3):286\u201391. https:\/\/doi.org\/10.1159\/000288230 .","journal-title":"Urol Int"},{"issue":"4","key":"389_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000326081","volume":"87","author":"F Zaman","year":"2011","unstructured":"Zaman F, Poullis C, Bach C, Moraitis K, Junaid I, Buchholz N, et al. Use of a segmental thermoexpandable metal alloy stent in the management of malignant ureteric obstruction: a single centre experience in the UK. Urol Int. 2011;87(4):405\u201310. https:\/\/doi.org\/10.1159\/000326081 .","journal-title":"Urol Int"},{"key":"389_CR35","unstructured":"Aintree University Hospitals. Cost-effectiveness of using permanent Memokath Stent (MMK) compared to JJ stent (unpublished)."},{"issue":"9","key":"389_CR36","first-page":"875","volume":"64","author":"LL Gonzalez","year":"2011","unstructured":"Gonzalez LL, Borda AP, Gonzalez ER, Medina JS, Martinez LC, Parra ROA. Decision analysis for economic evaluation of the management of chronic obstructive uropathy. Arch Esp Urol. 2011;64(9):875\u201381.","journal-title":"Arch Esp Urol"},{"key":"389_CR37","doi-asserted-by":"publisher","first-page":"A434","DOI":"10.1089\/end.2012.2001","volume":"26","author":"MF Zaman","year":"2012","unstructured":"Zaman MF, Goyal A, Bach C, Kachrilas S, Mukherjee K, Junaid I, et al. A cost-effectiveness model for the Memokath 051TM in malignant ureteric obstruction. J Endourol. 2012;26:A434\u20135. https:\/\/doi.org\/10.1089\/end.2012.2001 .","journal-title":"J Endourol"},{"issue":"7052","key":"389_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","volume":"313","author":"M Drummond","year":"1996","unstructured":"Drummond M, Jefferson T. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313(7052):275\u201383.","journal-title":"BMJ"},{"key":"389_CR39","unstructured":"National Institute for Health and Care Excellence. Medical Technologies Evaluation Programme: process guide. 2011. http:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/NICE-guidance\/NICE-medical-technologies\/Medical-technologies-evaluation-programme-process-guide.pdf . Accessed 6 Feb 2015."},{"key":"389_CR40","unstructured":"Department of Health. NHS reference costs 2015-16. London. 2016. https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-collection-guidance-for-2015-to-2016 . Accessed 11 May 2017."}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-018-0389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-018-0389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-018-0389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T19:14:09Z","timestamp":1570994049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-018-0389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1007\/s40258-018-0389-3","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"3 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Newcastle upon Tyne Hospitals and York Health Economics Consortium are funded by NICE to act as an EAC for the Medical Technologies Evaluation Programme.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This summary of the Medical Technology Guidance was produced following publication of the final guidance report. This summary has not been externally peer reviewed by\n                      Applied Health Economics and Health Policy\n                      .One of the authors (AS) is an NHS employee; the NHS has a financial interest in the guidance issued by NICE as a result of this work. Seven of the authors (MJ, EET, CM, RM, AP, HW and JC) work for the EAC, but otherwise have no conflicts of interest. LM is an employee of NICE.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}